|
Jun 24
|
Bristol Myers' (BMY) Krazati Gets FDA Nod for Colorectal Cancer
|
|
Jun 19
|
Roche (RHHBY), Ascidian Team Up for RNA Exon Editing Therapeutics
|
|
Jun 19
|
Terns (TERN) Gains 13.6% YTD: Will the Momentum Continue?
|
|
Jun 19
|
The past three years for Ligand Pharmaceuticals (NASDAQ:LGND) investors has not been profitable
|
|
Jun 18
|
Ligand Collaborator Merck Receives FDA Approval for CAPVAXIVE™ (Pneumococcal 21-valent Conjugate Vaccine) for Adults
|
|
Jun 14
|
Shattuck (STTK) Announces Positive Interim Data on Cancer Drug
|
|
Jun 14
|
Bristol Myers (BMY) Gets FDA Nod for Label Expansion of Augtyro
|
|
Jun 14
|
What Makes Ligand (LGND) a New Strong Buy Stock
|
|
May 23
|
Ligand to Participate in Upcoming Investor Conferences
|
|
May 21
|
AstraZeneca (AZN) Plans to Generate $80B in Revenues by 2030
|
|
May 21
|
Dyne (DYN) Soars 28% on New Data From Muscle Disease Studies
|
|
May 21
|
PTC Therapeutics (PTCT) Up as EC Returns CHMP Opinion on DMD Drug
|
|
May 20
|
BeiGene's (BGNE) Shares Surge 32% in a Month: Here's Why
|
|
May 17
|
Eli Lilly's (LLY) Efsitora Matches Daily Insulins in A1C Control
|
|
May 17
|
Amgen's (AMGN) Tarlatamab Receives FDA Approval for SCLC
|
|
May 17
|
Ionis (IONS), Biogen Down on Ending Development of ALS Drug
|
|
May 15
|
FDA Delays Decision on Ascendis' (ASND) Hormone Therapy Filing
|
|
May 14
|
Allogene (ALLO) Q1 Earnings in Line With Estimates, Sales Lag
|
|
May 14
|
Novo Nordisk (NVO) Up 3% as Haemophilia Drug Meets Study Goals
|
|
May 14
|
Merck (MRK) Ends Keytruda Combo Melanoma Study Due to Futility
|